Advanced search×

Evaluation of dense polylactic acid/beta-tricalcium phosphate scaffolds for bone tissue engineering.

J Biomed Mater Res A 95(3):717-26 (2010) PMID 20725979

Advances in biomaterial fabrication have introduced numerous innovations in designing scaffolds for bone tissue engineering. Often, the focus has been on fabricating scaffolds with high and interconnected porosity that would allow for cellular seeding and tissue ingrowth. However, such scaffolds typically lack the mechanical strength to sustain in vivo ambulatory stresses in models of load bearing cortical bone reconstruction. In this study, we investigated the microstructural and mechanical properties of dense PLA and PLA/beta-TCP (85:15) scaffolds fabricated using a rapid volume expansion phase separation technique, which embeds uncoated beta-TCP particles within the porous polymer. PLA scaffolds had a volumetric porosity in the range of 30 to 40%. With the embedding of beta-TCP mineral particles, the porosity of the scaffolds was reduced in half, whereas the ultimate compressive and torsional strength were significantly increased. We also investigated the properties of the scaffolds as delivery vehicles for growth factors in vitro and in vivo. The low-surface porosity resulted in sub optimal retention efficiency of the growth factors, and burst release kinetics reflecting surface coating rather than volumetric entrapment, regardless of the scaffold used. When loaded with BMP2 and VEGF and implanted in the quadriceps muscle, PLA/beta-TCP scaffolds did not induce ectopic mineralization but induced a significant 1.8-fold increase in neo vessel formation. In conclusion, dense PLA/beta-TCP scaffolds can be engineered with enhanced mechanical properties and potentially be exploited for localized therapeutic factor delivery.

DOI: 10.1002/jbm.a.32868
Version: za2963e q8zad q8zb4 q8zcf q8zd9 q8zec q8zf2 q8zgc

Similar articles you may find interesting…

  1. Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma.

    Cancer (2013) PMID 23633392

    These results demonstrate that TMZ can be safely combined with a farnesyltransferase inhibitor and that this regimen is active, although the current study cannot determine the relative contributions of the 2 agents or the contribution of the novel administration schedule. Cancer 2013. © 2013 Americ...
  2. Long term evaluation of morphometric and ultrastructural changes of testes of alloxan-induced diabetic rats.

    Acta Cir Bras 28(4):256-65 (2013) PMID 23568233

    To evaluate in a long term the morphometric and ultrastructural changes in seminiferous tubules (ST) of normal and diabetic rats, and to correlate any changes with animal age and diabetes duration. Sixty male Wistar rats, three months-old, were randomly divided into t...
  3. A prospective, randomized controlled preclinical trial to evaluate different formulations of biphasic calcium phosphate in combination with ...

    J Oral Implantol 39(2):133-9 (2013) PMID 23611676

    Many patients and clinicians would prefer a synthetic particulate bone replacement graft, but most available alloplastic biomaterials have limited osteogenic potential. An alloplast with increased regenerative capacity would be advantageous for the treatment of localized alveolar rid...